Kanazaki, Ria
Smith, Ben
Bu, Stella
Girgis, Afaf
Connor, Susan J
Funding for this research was provided by:
Pfizer (35313877)
Article History
Received: 28 July 2023
Accepted: 8 May 2024
First Online: 13 May 2024
Declarations
:
: The study was approved by the South Western Sydney Local Health District Human Research Ethics Committee (LNR/17/LPOOL/469). All study participants provided their informed consent prior to enrolment in the study.
: Not applicable.
: RK has received educational support from Abbvie, Takeda, Janssen and Ferring. SC has received honoraria for Advisory Board participation, speaker fees, educational support and/or research support from: Abbvie, Amgen, BMS, Celltrion, Chiesi, DrFalk, Eli-Lilly, Ferring, Fresenius Kabi, GSK, Janssen, MSD, Novartis, Organon, Pfizer, Sandoz, Takeda, Agency for Clinical Innovation, Gastroenterological Society of Australia, Medical Research Future Fund, South Western Sydney Local Health District, Sydney Partnership for Health, Research and Enterprise (SPHERE) and The Leona M and Harry B Helmsley Charitable Trust. The remaining authors have no conflicts of interest to declare.